We are delighted to announce and share the acceptance of our new peer-reviewed publication in “Molecular Therapy – Nucleic Acids” highlighting our research findings and charactersation of our cLNP002 mRNA-formulation for spatial expression of a Tie2-agonist in the vascular endothelium of the lung.

These findings build the basis for our motivation and vision to translate this concept into clinical practice.
Have a look at our paper and spread the news!

Contact for additional information:  
Dr. Ansgar Santel, Head of Translational Research and Alliance Management  

T: +49(0)3302-202 240-0  
E-Mail: a.santel@pantherna-therapeutics.com